Dermal Fillers Market Size, Share & Industry Analysis, By Material (Hyaluronic Acid, Calcium Hydroxylapatite, Poly-L-lactic Acid, PMMA (Poly (Methyl Methacrylate)), Fat Fillers, and Others), By Product (Biodegradable and Non-Biodegradable), By Application (Scar Treatment, Wrinkle Correction Treatment, Lip Enhancement, Restoration of Volume/Fullness, and Others), By End-user (Specialty & Dermatology Clinics, Hospitals & Clinics, and Others), and Regional Forecast, 2024-2032

The global dermal fillers market size was valued at USD 5.08 billion in 2023 and is projected to grow from USD 5.44 billion in 2024 to USD 10.16 billion by 2032, exhibiting a CAGR of 8.1% during the forecast period (2024-2032).

The current trend indicates a significant and continuous rise in the demand for cosmetic procedures, particularly non-invasive techniques. Dermal fillers are gel-like substances injected beneath facial skin to enhance aesthetics, addressing issues, such as facial lines, wrinkles, lip enhancement, restoration of lost volume, and acne scars. As disposable income grows globally, particularly in emerging regions, it is anticipated that these procedures will observe an increase in procedural volumes to enhance facial features. Furthermore, taboos linked to cosmetic procedures have witnessed a substantial decrease with increasing awareness about dermal filler procedures. Such changes in attitudes are escalating the adoption of these products. 

In response to these favorable growth trends, numerous facial injectable manufacturing companies have invested substantially in R&D initiatives. These R&D initiatives have resulted in the development of many products that exhibit notably enhanced aesthetic results. Product launches are expected to contribute to the market's growth during the forecast period. New product launches with a wide range of applications are increasing the demand for aesthetic procedures, which is expected to grow the market during the forecast period.

In 2020, lockdowns were imposed due to the COVID-19 pandemic, where the cosmeceuticals sector witnessed a reduction in production, supply chain disruptions, and import and export limitations due to flight closures. However, in 2021, the global dermal fillers market recovered after the decrease in COVID-19-positive cases and the relaxation of the COVID-19 guidelines.

Dermal Fillers Market Trends

Increasing Trend of Male Individuals Opting for Dermal Fillers

The shift of interest of almost all demographic groups toward non-invasive and minimally invasive procedures is one of the most prominent trends witnessed by the global market. There is a growing tendency among male demographic groups to undergo procedures to enhance their appearances.

• For instance, according to a news article published by the American Society of Plastic Surgeons, the popularity of cosmetic injectable procedures is rising among males. They are turning toward procedures, such as dermal fillers and botox, to enhance their appearance.

As per the ISAPS Global Survey Results, 2021, around 11.1% of global non-surgical procedures are chosen by the male demographic, with a particular preference for hyaluronic acid treatments. With dermatologists increasingly focusing on this demographic, there is potential for this percentage to rise over the forecast period. Consequently, these emerging trends are anticipated to create a new patient population for companies in the global market, significantly contributing to the dermal fillers market growth over the forecast period.

Request a Free sample to learn more about this report.

Dermal Fillers Market Growth Factors

Rise in Demand for Minimally Invasive Cosmetic Procedures Drive the Expansion of the Market

Substantial growing demand for facial aesthetics is one of the most critical global dermal fillers market drivers. The easier and painless procedures have been opted for by individuals for a youthful appearance and radiant face in recent times. As there are risks associated with invasive surgeries that require additional time for recovery, the shift of patients toward minimally invasive cosmetic procedures is taking place.

• According to the American Society of Plastic Surgeons 2023 report, approximately 23,672,269 minimally invasive cosmetic procedures occurred in 2023. These robust statistics further illustrate the significant surge in the popularity of minimally invasive cosmetic procedures.

Manufacturers of filler products have also experienced a positive impact with an increase in demand for minimally invasive aesthetic procedures. Several companies in the aesthetics sector are progressively introducing products to address the increasing demand for medical aesthetics.

• For instance, in May 2023, Galderma launched RESTYLANE EYELIGHT in Canada. A hyaluronic acid injectable dermal filler that helps to reduce under-eye grooves caused by lack of volume in the under-eye area. Such launches augmented the increased demand for these procedures.

Rising Demand for Dermal Filler Procedures Coupled with Growing R&D is Set to Boost Market Expansion

One of the other most prominent market drivers is the increasing R&D initiatives by companies to develop new and advanced fillers. These new products have diverse aesthetic indications. The growing number of applications for minimally invasive or non-invasive procedures is anticipated to fuel market growth.

Furthermore, numerous clinical trials within diverse research and development endeavors also play a constructive role in fostering market expansion.

• For instance, in November 2023, CollPlant Biotechnologies announced the patent grant of its photocurable dermal filler product by the U.S. Patent and Trademark Office. The product has skin lifting and tissue regeneration capacity.

Furthermore, the increasing number of dermal fillers procedures throughout the years also contributed to the market's expansion.

• For instance, according to the International Society of Aesthetic Plastic Surgery (ISAPS), in 2021, procedures for hyaluronic acid fillers were conducted globally, approximately 5,279,344 procedures took place in 2021. An increase of 30.3% was observed in 2020. The anticipation of a substantial increase in aesthetic procedures is also projected to contribute to the market growth throughout the forecast period.

These above mentioned factors are the key global market drivers.

RESTRAINING FACTORS

High Costs and Side Effects Associated with Product to Hamper Market Growth

With numerous aesthetic applications, several constraining factors are anticipated to hamper the growth of the global market throughout the forecast period. The exacerbated cost associated with these products is one factor that inhibits the development of the global market.

The cost varies according to the practitioner’s expertise and qualifications performing the treatment, the time associated with the procedure, and the efforts that the treatment requires. Moreover, the transient effects of the products might necessitate individuals to undergo repeated aesthetic filler treatments. This imposes a financial strain on individuals, potentially discouraging them from choosing elective procedures.

In addition, the adverse effects after administration of filler injections significantly contribute toward reducing the market growth. The possible adverse events associated with the procedures are pain, bruising, or swelling at the injection site'; redness, bruising, infections, and lumps & bumps. Moreover, some occasional adverse reactions experienced in person are vision loss and severe scarring due to accidental injection of fillers into blood vessels. Thus, these factors restrain the growth of the market.

Dermal Fillers Market Segmentation Analysis

By Material Analysis

Hyaluronic Acid Segment to Lead the Market Due to Its Long-Lasting Effects 

The global market is divided into various segments based on material, including hyaluronic acid, calcium hydroxylapatite, Poly-L-lactic acid, PMMA (poly (Methyl Methacrylate)), fat fillers, and others.

The hyaluronic acid segment is projected to dominate the market throughout the forecast period. This growth is driven by the introduction of new products in this segment. The increasing demand for hyaluronic acid fillers is attributed to the safety and long-lasting effects associated with these products.

• For instance, in August 2023, Maypharm launched a hyaluronic acid dermal filler called SEDY FILL, which is used for non-surgical b006Fdy shape correction.

Moreover, the launch of new products in the hyaluronic acid category in prominent countries, such as the U.S. and U.K., is expected to boost the growth of this segment between 2024 and 2032 further.

• In February 2021, Merz Aesthetics introduced an injectable hyaluronic acid filler with Lidocaine called BELOTERO BALANCE (+) in the U.S. market.

The calcium hydroxylapatite segment held a significant share of the market in 2023, primarily due to its safety features. The introduction of new products by key players in this segment also contributes to its growth.

• For instance, in April 2023, Allergan Aesthetics launched HArmonyCa, an injectable dermal filler with Lidocaine that utilizes calcium hydroxylapatite (CaHA) for sustained collagen stimulation and hyaluronic acid for immediate lift.

The fat fillers segment is expected to experience significant growth with a notable CAGR throughout the forecast period, driven by an increase in procedures involving fat fillers in regions such as North America.

On the other hand, the PMMA (Poly (Methyl Methacrylate)) segment has a limited market share due to the lack of biodegradability of its products. However, the relaunch of products containing Poly-L-lactic Acid is expected to drive growth in the Poly-L-lactic Acid segment.

To know how our report can help streamline your business, Speak to Analyst

By Product Analysis

Robust Usage of Biodegradable Products to Propel Segment Growth

Based on product, the market is classified into biodegradable and non-biodegradable.

The biodegradable segment is expected to dominate the market during the forecast period. This is primarily due to the wide availability and versatile applications of biodegradable products, which offer enhanced aesthetics compared to non-biodegradable alternatives. Furthermore, the growth of the biodegradable segment is fueled by the introduction of new, safer products and stringent regulations, as well as increased research and development efforts by both established and emerging players.

An instance of this trend was observed in March 2023, when Hallura Ltd., an aesthetic company based in Israel, announced positive results from their multi-site European clinical trial for their BiOLinkMatrix platform, a next-generation hyaluronic acid dermal filler. The filler has been evaluated for its safety and effectiveness in various applications, such as cheek enhancement, lip enhancement, and correction of nasolabial folds.

On the other hand, the non-biodegradable segment held the lowest market share in 2023. However, the adoption rates for non-biodegradable products are relatively lower due to their non-temporary nature. The decline in this segment's market growth is attributed to the non-decomposable nature of these products.

By Application Analysis

Wrinkle Correction Treatment Segment Dominated the Market due to Introduction of New Products 

The global market is classified into various segments based on application, including scar treatment, wrinkle correction treatment, lip enhancement, restoration of volume/fullness, and others.

In terms of application, the wrinkle correction treatment segment dominated the market in 2023 due to a surge in the demand for wrinkle correction procedures. Furthermore, the segment's growth is projected to be driven by the introduction of new products in this category.

• For instance, Teoxane's RHA Redensity, which is used to reduce facial lines and wrinkles, received approval from the U.S. Food and Drug Administration in January 2023.

The lip enhancement segment also held a significant market share, primarily due to the increasing number of lip enhancement procedures. The growing demand for minimally invasive aesthetic improvements for the lips is expected to fuel this segment.

• In December 2023, Evolus, Inc. entered into an exclusive licensing agreement with Symatese to distribute their next-generation fillers, including Estyme facial fillers for lip indications, in the U.K. and Europe.

The restoration of volume/fullness segment ranked as the third-largest segment. This can be attributed to the launch of new products by key players, such as Allergan's (AbbVie, Inc.) JUVEDERM VOLUX focuses on providing restoration effects. However, the scar treatment segment is projected to have a relatively lower market share during the forecast period.

By End-user Analysis

Specialty & Dermatology Clinics Segment to Dominate the Market Due to Increasing Collaborations Between Clinics and Stores

According to end-user categorization, the market is divided into specialty & dermatology clinics, hospitals & clinics, and others.

The specialty & dermatology clinics segment is projected to hold the largest share during the forecast period. This dominant position is supported by the high volume of procedures performed in specialty & dermatology clinics. Furthermore, the segment's growth is being fueled by increasing collaborations between clinics and stores, which enhances product availability.

• For instance, in June 2023, CAVENDISH CLINIC partnered with John Lewis Plc to provide aesthetic and beauty treatments, including these fillers, in their stores across the U.K. Additionally, certain procedures such as wrinkle correction do not require a hospital stay, contributing to the market's expansion.

The hospitals & clinics segment captured the second-largest market share in 2023, mainly due to the significant number of facial injectable procedures carried out in these healthcare facilities. On the other hand, the others segment experienced relatively lower market growth and share.

REGIONAL INSIGHTS

The global market is divided into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

To get more information on the regional analysis of this market, Request a Free sample

The dermal fillers market size in North America was valued at USD 1.98 billion in 2023. The region is expected to maintain a dominant share of the global market from 2024 to 2032 due to factors, such as high awareness, increased disposable income, and a significant number of cosmetic procedures in the region.

• For example, the American Society of Plastic Surgeons (ASPS) reported approximately 1,498,361 cosmetic procedures performed in the U.S. in 2022. Additionally, the region's growth is expected to be fueled by new product launches and robust regulatory approvals.

Europe held the second-highest market share in 2023. The region's growth can be attributed to the increasing preference for dermal filler procedures among individuals in key European countries and greater expenditure on research and development (R&D).

• For instance, Germany witnessed around 254,743 hyaluronic acid procedures, making it a prominent country for cosmetic procedures in Europe, according to the ISAPS Global Survey Results 2021.

Asia Pacific is anticipated to experience the highest growth rate during the forecast period. This is driven by advancements in healthcare settings and infrastructure, a growing aging population, and individuals' increasing awareness of their physical appearance. Moreover, companies focusing on research and development to introduce new products in the Asian market contribute to the region's strong growth.

• For instance, Croma-Pharma initiated a clinical trial in June 2023 for the approval of Princess Volume Plus Lidocaine, a hyaluronic acid dermal filler, in the Chinese market.

Latin America and the Middle East & Africa have a relatively low dermal fillers market share. However, the market’s growth in these regions can be driven by increasing healthcare expenditure on infrastructure and the entry of new players with innovative products.

• For instance, Turkey witnessed 192,023 hyaluronic acid procedures in 2021, according to the International Society of Aesthetic Plastic Surgery (ISAPS).

Key Industry Players in Dermal Fillers Market

Strong Product Portfolio of ALLERGAN (AbbVie, Inc.) to Escalate the Company to a Dominant Position

The dermal fillers market is characterized by a diverse competitive landscape, with the presence of both established corporations and emerging players.

In the current market scenario, ALLERGAN (AbbVie, Inc.) holds a dominant position, generating a significant portion of the global dermal fillers market's revenue. This market leadership is attributed to the company's strong portfolio of products, including the JUVEDERM Collection of Hyaluronic Acid (HA) fillers. The versatile application areas of the JUVEDERM Collection have further contributed to ALLERGAN's strong position in the global dermal fillers industry.

However, other companies, such as Merz Pharma and Revance Therapeutics, Inc., are actively engaged in strategic initiatives, such as launching new products and fostering collaborations to enhance their market presence. Similarly, Sinclair Pharma and Galderma, prominent players in the industry, are focusing on introducing new products in key regions to augment their revenue share in the global market.

LIST OF TOP DERMAL FILLERS COMPANIES:

• ALLERGAN (AbbVie, Inc.) (U.S.)


• Revance Therapeutics, Inc. (U.S.)


• Merz Pharma (Germany)


• Galderma (Switzerland)


• Sinclair Pharma (U.K.)


• BIOPLUS CO., LTD. (South Korea)


• Bioxis Pharmaceuticals (France)


• SCULPT Luxury Dermal Fillers Ltd. (Czech Republic)


• DR. Korman (Israel)


• Prollenium Medical Technologies (Canada)


• Suneva Medical (U.S.)


• Anika Therapeutics, Inc. (U.S.)

KEY INDUSTRY DEVELOPMENTS:

• October 2023: Prollenium Medical Technologies announced its acquisition of SoftFil medical devices with the aim of innovating potent tools that deliver optimal results for practitioners and patients.


• February 2023: Galderma launched Radiesse (+) Lidocaine injectable implants, specifically designed for deep injection (subdermal and supraperiosteal) to enhance the contour of the jawline and address moderate to severe loss in adults aged 21 and above.


• January 2023: AbbVie Inc.'s subsidiary Allergan introduced JUVÉDERM VOLUX XC, a treatment for adults over 21 years old experiencing moderate to severe loss of jawline definition.


• March 2021: Galderma reintroduced Sculptra (injectable Poly-L-lactic acid) in Europe, introducing an updated administration protocol.


• February 2021: Allergan Aesthetics and CollPlant announced a global commercial agreement and collaboration to utilize their plant-derived recombinant human collagen (rhCollagen) in the development and commercialization of dermal soft tissue fillers, incorporating Allergan's proprietary technology.

REPORT COVERAGE

The report provides market segmentation, size and growth rate. It includes a detailed description of the global market analysis. It focuses on key facts such as the overview of the product types, regulatory scenarios by key countries, reimbursement scenarios by key countries, overview of new product launches/approvals, and pipeline analysis. Additionally, the report offers insights into market trends and highlights vital strategies by market players. Besides the mentioned factors, the report encompasses several factors contributing to the market's growth in recent years.

To gain extensive insights into the market, Request for Customization

Report Scope & Segmentation